World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
127
Citations
56563
World Ranking
2840
National Ranking
1581

Overview

Donald P. Tashkin is affiliated with the University of California, Los Angeles in the United States. The primary area of their research is within Medicine, with a strong focus on Pulmonary and Respiratory Medicine. This subfield constitutes the majority of their scholarly work, alongside contributions to Physiology, Pathology and Forensic Medicine, Epidemiology, and Emergency Medical Services.

The main topics covered in their research include Chronic Obstructive Pulmonary Disease (COPD), Asthma and respiratory diseases, Systemic Sclerosis and related diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory Support and Mechanisms, Inhalation and respiratory drug delivery, as well as Inflammatory Myopathies and Dermatomyositis.

Among their recent publications are the following papers:

  • Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease, 2022, American Journal of Respiratory and Critical Care Medicine
  • Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II, 2020, ACR Open Rheumatology
  • Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD, 2020, CHEST Journal
  • Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study, 2022, American Journal of Respiratory and Critical Care Medicine
  • The use of nebulized pharmacotherapies during the COVID-19 pandemic, 2020, Therapeutic Advances in Respiratory Disease

Frequently publishing in several journals, they have contributed extensively to:

  • CHEST Journal
  • American Journal of Respiratory and Critical Care Medicine
  • Annals of the American Thoracic Society
  • International Journal of COPD
  • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation

Their collaborative network includes repeated co-authorship with several researchers such as:

  • Igor Barjaktarević
  • Christopher B. Cooper
  • Prescott G. Woodruff
  • MeiLan K. Han
  • David Couper

Best Publications

  • A 4-Year Trial of Tiotropium in chronic obstructive pulmonary disease

    Donald P. Tashkin;Bartolome Celli;Stephen Senn;Deborah Burkhart

  • Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study

    Nicholas R. Anthonisen;John E. Connett;James P. Kiley;Murray D Altose

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

    Paul D. Scanlon;John E. Connett;Lance A. Waller;Murray D. Altose

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

    Prescott G. Woodruff;R. Graham Barr;Eugene Bleecker;Stephanie A. Christenson

  • Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

    Marc Decramer;Bartolome Celli;Steven Kesten;Theodore Lystig

  • Pulmonary hazards of smoking marijuana as compared with tobacco

    Tzu-Chin Wu;Donald P. Tashkin;Behnam Djahed;Jed E. Rose

  • C‐reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

    S. F P Man;John E Connett;N. R. Anthonisen;R. A. Wise

  • Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

    DP Tashkin;R Kanner;W Bailey;S Buist

  • Gender Bias in the Diagnosis of COPD

    Kenneth R. Chapman;Donald P. Tashkin;David J. Pye

  • Bronchodilator responsiveness in patients with COPD

    D P Tashkin;B Celli;Marc Decramer;D Liu

  • Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease

    Donald P. Tashkin;Murray D. Altose;John E. Connett;Richard E. Kanner

  • A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD

    Daniel J. Weiss;Richard Casaburi;Robin Flannery;Michelle LeRoux-Williams

  • Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck

    Zuo Feng Zhang;Hal Morgenstern;Margaret R. Spitz;Donald P. Tashkin

  • Metered-Dose Inhaler Adherence in a Clinical Trial

    Cynthia S. Rand;Robert A. Wise;Mitchell Nides;Michael S. Simmons

  • The Lung Health Study: Airway Responsiveness to Inhaled Methacholine in Smokers with Mild to Moderate Airflow Limitation

    Donald P. Tashkin;Murray D. Altose;Eugene R. Bleecker;John E. Connett

  • Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study

    Mia Hashibe;Hal Morgenstern;Yan Cui;Donald P. Tashkin

  • Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

    Ronald G. Ungerer;Donald P. Tashkin;Daniel Furst;Philip J. Clements

  • Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1. The Lung Health Study

    N. R. Anthoisen;J. E. Connett;J. P. Kiley;M. D. Altose

Frequent Co-Authors

Bartolome R. Celli
Bartolome R. Celli Brigham and Women's Hospital
Marc Decramer
Marc Decramer KU Leuven
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Jonathan G. Goldin
Jonathan G. Goldin University of California, Los Angeles
Robert A. Wise
Robert A. Wise Johns Hopkins University School of Medicine
Stephen I. Rennard
Stephen I. Rennard University of Nebraska Medical Center
John E. Connett
John E. Connett University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering Medicine in the USA, it’s worth exploring flexible and affordable online nursing programs. Many students start with an associate degree in nursing and find online adn programs that are accessible and have fewer entry barriers.

For those already working as registered nurses, advancing your education can open up more opportunities. The cheapest bsn programs are designed to be cost-effective, allowing you to earn a Bachelor of Science in Nursing online while balancing work and family commitments.

If you have a non-nursing bachelor’s degree but want to transition into nursing, consider non nursing bachelor's to msn online programs. These accelerated pathways help non-nurses fast-track into advanced nursing roles without starting over.

For those seeking leadership or research positions, online nursing phd programs are available and can be completed from anywhere, often at a much lower cost than traditional on-campus options. Each pathway offers unique benefits and helps tailor your healthcare career to your goals.

Best Scientists Citing Donald P. Tashkin

Trending Scientists

Recently Published Articles